Interleukin-2-dextran complex

Drug Profile

Interleukin-2-dextran complex

Alternative Names: IL-2-dextran complex; IL-2-encapsulated dextran micropheres; OctoDEX™-IL-2; sustained release IL-2

Latest Information Update: 14 May 2008

Price : $50

At a glance

  • Originator OctoPlus
  • Class Adjuvants; Antineoplastics; Interleukins; Lymphokines
  • Mechanism of Action Immunostimulants; Interleukin 2 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 14 May 2008 Discontinued - Preclinical for Cancer in Netherlands (unspecified route)
  • 18 Aug 2003 Preclinical trials in Cancer in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top